ReRT
Phase NA Recruiting
1,800 enrolled
FIBROTHERME
Phase NA Recruiting
110 enrolled
SHERLOCK
Recruiting
7,000 enrolled
Topical Diclofenac for Prevention of Radiation-induced Dermatitis
Phase NA Recruiting
156 enrolled
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
233 enrolled
Feasibility Study of CBCT for IGRT in Cancer Patients
Phase NA Recruiting
50 enrolled
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase 1/2 Recruiting
300 enrolled
MOMENTUM
Recruiting
8,000 enrolled
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
Phase NA Recruiting
860 enrolled
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Phase 1 Recruiting
150 enrolled
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
250 enrolled
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Phase 2 Recruiting
24 enrolled
PIKALO-1
Phase 1/2 Recruiting
720 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
Virtual Rehabilitation for Cancer Survivors
Phase NA Recruiting
388 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
216 enrolled
Improving Care for Rural Patients With Solid Tumors
Phase NA Recruiting
320 enrolled
SCANDARE
Phase NA Recruiting
1,050 enrolled
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2 Recruiting
740 enrolled
Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
51 enrolled
TAGNOT
Phase 1/2 Recruiting
58 enrolled
CAMPERR
Recruiting
7,000 enrolled
SCORE
Recruiting
9,600 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
Contrast-enhanced Ultrasound for Sentinel Node Detection
Phase 2/3 Recruiting
91 enrolled
PETRiS
Recruiting
850 enrolled
LIBERATE
Recruiting
2,500 enrolled
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Phase 4 Recruiting
100 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Recruiting
270 enrolled
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Phase 1/2 Recruiting
126 enrolled
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Phase 1/2 Recruiting
300 enrolled
CAPTIV-8
Phase 2 Recruiting
200 enrolled
OvAR-Y
Recruiting
10 enrolled
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Phase 1 Recruiting
40 enrolled
IC-Growth
Phase NA Recruiting
180 enrolled
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Phase 2 Recruiting
51 enrolled
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
115 enrolled
MOIO
Phase 3 Recruiting
646 enrolled
Brodalumab in the Treatment of Immune-Related Adverse Events
Phase 1 Recruiting
11 enrolled
A Multicenter Cancer Biospecimen Collection Study
Recruiting
1,650 enrolled
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
Phase NA Recruiting
150 enrolled
MOHCCN-O
Recruiting
500 enrolled
VALOROUS
Phase NA Recruiting
250 enrolled
COACH
Phase NA Recruiting
625 enrolled
OCTANE
Recruiting
10,000 enrolled
SkinHealth
Recruiting
420 enrolled
LEARN
Recruiting
300 enrolled